Implementation of Coordinated Global Oral Poliovirus Vaccine Serotype 2 Cessation: Risks of Potential Non-Synchronous Cessation
by Radboud J. Duintjer Tebbens, Lee M. Hampton, and Kimberly M. Thompson, BMC Infectious Diseases 2016; 16:231, doi: 10.1186/s12879-016-1536-9.

Answers to frequently asked questions

What are the study’s main findings?
What are the study’s main recommendations?
Background on polio

What are the study’s main findings?

What are the study’s main recommendations?